Trial Profile
Randomized, Non-blinded, Two-way Crossover Study to Establish the Bioequivalence Between a Rivaroxaban Tablet 10 mg and a Rivaroxaban Granule 10 mg in Japanese Healthy Adult Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 04 Sep 2015
Price :
$35
*
At a glance
- Drugs Rivaroxaban (Primary) ; Rivaroxaban
- Indications Embolism; Venous thrombosis
- Focus Pharmacokinetics
- Sponsors Bayer
- 04 Sep 2015 New trial record